HIV Diagnostics Market Analysis by Product (Instruments, Consumables), by Test Type (Viral load, Antibody, CD4 Tests), by End User (Blood Banks, Hospitals, Diagnostic Laboratories), and by Region - Forecast to 2029

Request Sample Page

The global HIV diagnostics market size is estimated to be USD 3,740.2 million in 2021 and is expected to witness a CAGR of 10.84% during the forecast period. Growing global incidence of HIV/aids is a key driver for the growth of the global HIV diagnostics market. Additionally, the increasing number of blood transfusions and blood donations, and benefits presented by point-of-care instruments & kits are some of the other drivers propelling the market growth. Nevertheless, patient’s personal data security concerns constrain the growth, and high cost of deployment limits better facilities to be offered to the patients are expected to restrain the global market growth.

Global HIV Diagnostics Market Size (USD Million), 2021-2029

Source: Erevna Healthcare

By Product

Based on product, the market is segmented into instruments, consumables, and software & services. In 2021, the consumables segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is attributed to the regular purchase of consumables by laboratories and hospitals due to the growing incidence of HIV/AIDS worldwide. Instruments segment projected to grow at a profitable CAGR during the forecast period. This is attributed to growing initiatives from governments in different regions to fight HIV/AIDS globally.

By Test Type

Based on test type, the market is categorized into viral load test, antibody test, CD4 test, tests for viral identification, and tests for early infant diagnosis. In 2021, the antibody test accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is due to the growing technological developments in HIV diagnostics market worldwide. The tests for viral identification segment is anticipated to grow at a profitable CAGR during the forecast period, due to the growing investments from various public and private sector players in the market.

By End User

Based on end user, the market is categorized into blood banks, hospitals, diagnostic laboratories, home care settings, and others. In 2021, the diagnostic laboratories segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is due to increasing investments and technological advancements in the diagnostic laboratories worldwide. The hospital segment is anticipated to grow at a profitable CAGR during the forecast period, due to growing cases of HIV/AIDS especially in the developing and underdeveloped economies globally.

Regional Insights

In 2021, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the growing population in many countries in the region, availability of advance diagnostic instruments, improving healthcare infrastructure, and the presence of major manufacturers in the region. Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the unmet demands in the market, escalating demand for advanced medication and treatment, and growing focus on biopharmaceutical companies in this region.

Competitor Insights

Some of the key players in the HIV diagnostics market are F. Hoffmann-La Roche AG (Switzerland); Siemens AG (Germany); Abbott Laboratories (U.S.); Thermo-Fisher Scientific Inc. (U.S.); Danaher Corporation (U.S.); Merck KGaA (Germany); Hologic, Inc. (U.S.); Becton, Dickinson and Company (U.S.); and Bio-Rad Laboratories (U.S.).The leading players operating in the HIV diagnostics industry are adopting various strategies including R&D investments, adoption of advanced techniques, mergers & acquisitions, and regional expansions to capture a maximum revenue share.

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The HIV diagnostics market report is categorized into the following segments and subsegments:

HIV Diagnostics Market, By Product (Revenue, USD Million, 2021 – 2029)

  • Instruments
  • Consumables
    • Assays and Kits & Reagents
    • Other Consumables
  • Software & Services

HIV Diagnostics Market, By Test Type (Revenue, USD Million, 2021 – 2029)

  • Viral Load Tests
  • Antibody Tests
    • HIV-1 Screening Tests
      • ELISA
      • Rapid Tests
      • Home Access Dried Blood Spot
    • HIV-1 Confirmatory Tests
      • Western Blot Tests
      • Indirect Immune Fluorescent Antibody Assays (IFA)
      • Line Immunoassays (LIA)
      • Radio-Immunoprecipitation Assays (RIPA)
    • HIV-2 & Group O Diagnostic Tests
  • CD4 Tests
  • Tests for Viral Identification
  • Tests for Early Infant Diagnosis

HIV Diagnostics Market, By End User (Revenue, USD Million, 2021 – 2029)

  • Blood Banks
  • Hospitals
  • Diagnostic Laboratories
  • Home Care Settings
  • Other End Users

HIV Diagnostics Market, By Region (Revenue, USD Million, 2021 – 2029)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Scope of HIV Diagnostics Market Report:

Table of Contents: HIV Diagnostics Market 2021-2029

  1. Research Methodology
    1. Study Objectives
    2. Study Scope
    3. Research Assumptions
    4. Research Framework
      1. Research Models
        1. Bottom-up Approach
        2. Top-down Approach
        3. Data Triangulation
      2. Data Procurement
        1. Internal Database
        2. Secondary Research
        3. Purchased Database
        4. Primary Research
      3. Data Analysis
        1. Data Validation
        2. Market Size Estimation
        3. Market Forecast Model
      4. Quality Assessment
  1. Introduction: HIV Diagnostics
  2. Executive Summary
    1. Global Market Scenario
    2. Segment Market Scenario
    3. Geographic Market Scenario
    4. COVID-19 Impact
    5. Competitive Landscape
  3. Market Dynamics
    1. Market Drivers
      1. Driver 1
      2. Driver 2
      3. Driver 3
      4. Driver 4
      5. Driver 5
    2. Market Restraint
      1. Restraint 1
      2. Restraint 2
      3. Restraint 3
      4. Restraint 4
    3. Market Opportunities
      1. Opportunity 1
      2. Opportunity 2
      3. Opportunity 3
      4. Opportunity 4
    4. Market Trends
      1. Trend 1
      2. Trend 2
      3. Trend 3
      4. Trend 4
    5. Market Challenges
      1. Challenge 1
      2. Challenge 2
      3. Challenge 3
      4. Challenge 4

 

  1. Market Environment Analysis
    1. Porter’s 5 Forces Analysis
    2. PESTEL Analysis
    3. Value Chain Analysis
    4. SWOT Analysis
    5. Benchmark
  2. COVID-19 Impact Analysis: HIV Diagnostics Market
    1. COVID-19: Overview
    2. COVID-19 Impact on the Global Market
    3. COVID-19 Impact on the Regional Markets
  3. Market Analysis by Product
    1. Viral identification assays
      1. Viral identification assays Market Forecast, 2021-2029 (USD Million)
    2. Early infant diagnosis
      1. Early infant diagnosis Market Forecast, 2021-2029 (USD Million)
    3. Antibody tests
      1. Antibody tests Market Forecast, 2021-2029 (USD Million)
    4. Viral load testing
      1. Viral load testing Market Forecast, 2021-2029 (USD Million)
    5. CD4 testing
      1. CD4 testing Market Forecast, 2021-2029 (USD Million)
  1. Regional Market Analysis
    1. Regional Market Trends
    2. Regional Market: Comparative Analysis
  2. North America HIV Diagnostics Market
    1. North America HIV Diagnostics Market
      1. North America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Product, 2021-2029 (USD Million)
      2. S. HIV Diagnostics Market
        1. S. Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Product, 2021-2029 (USD Million)
        2. Canada HIV Diagnostics Market
          1. Canada Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Product, 2021-2029 (USD Million)
  1. Europe HIV Diagnostics Market
    1. Europe HIV Diagnostics Market
      1. Europe Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Product, 2021-2029 (USD Million)
      2. Germany HIV Diagnostics Market
        1. Germany Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Product, 2021-2029 (USD Million)
        2. UK HIV Diagnostics Market
          1. UK Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Product, 2021-2029 (USD Million)
          2. France HIV Diagnostics Market
            1. France Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Product, 2021-2029 (USD Million)
            2. Spain HIV Diagnostics Market
              1. Spain Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Product, 2021-2029 (USD Million)
              2. Italy HIV Diagnostics Market
                1. Italy Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Product, 2021-2029 (USD Million)
                2. Rest of Europe HIV Diagnostics Market
                  1. Rest of Europe Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Product, 2021-2029 (USD Million)
  1. Asia Pacific HIV Diagnostics Market
    1. Asia Pacific HIV Diagnostics Market
      1. Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Product, 2021-2029 (USD Million)
      2. Japan HIV Diagnostics Market
        1. Japan Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Product, 2021-2029 (USD Million)
        2. China HIV Diagnostics Market
          1. China Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Product, 2021-2029 (USD Million)
          2. India HIV Diagnostics Market
            1. India Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Product, 2021-2029 (USD Million)
            2. South Korea HIV Diagnostics Market
              1. South Korea Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Product, 2021-2029 (USD Million)
              2. Australia HIV Diagnostics Market
                1. Australia Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Product, 2021-2029 (USD Million)
                2. Rest of Asia Pacific HIV Diagnostics Market
                  1. Rest of Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Product, 2021-2029 (USD Million)
  1. Latin America HIV Diagnostics Market
    1. Latin America HIV Diagnostics Market
      1. Latin America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Product, 2021-2029 (USD Million)
      2. Brazil HIV Diagnostics Market
        1. Brazil Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Product, 2021-2029 (USD Million)
        2. Mexico HIV Diagnostics Market
          1. Mexico Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Product, 2021-2029 (USD Million)
          2. Argentina HIV Diagnostics Market
            1. Argentina Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Product, 2021-2029 (USD Million)
            2. Rest of Latin America HIV Diagnostics Market
              1. Rest of Latin America Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Product, 2021-2029 (USD Million)
  1. MEA HIV Diagnostics Market
    1. MEA HIV Diagnostics Market
      1. MEA Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Product, 2021-2029 (USD Million)
      2. GCC HIV Diagnostics Market
        1. GCC Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Product, 2021-2029 (USD Million)
        2. South Africa HIV Diagnostics Market
          1. South Africa Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Product, 2021-2029 (USD Million)
          2. Rest of MEA HIV Diagnostics Market
            1. Rest of MEA Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Product, 2021-2029 (USD Million)
  1. Competitor Analysis
    1. Market Share Analysis, 2021-2029
    2. Competitive Mapping
    3. Key Players Market Place Analysis
    4. Major Recent Developments
  2. Company Profiles
    1. Siemens AG (Germany)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    2. Roche Diagnostics (Switzerland)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    3. Abbott Laboratories (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    4. Danaher Corporation (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    5. Thermo-Fisher Scientific Inc. (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    6. Merck KGaA (Germany)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    7. Becton, Dickinson and Company (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    8. Hologic, Inc. (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    9. Alere Inc. (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    10. Bio-Rad Laboratories (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    11. Company 11
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    12. Company 12
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    13. Company 13
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    14. Company 14
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    15. Company 15
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    16. Others Prominent Players

Conclusion & Recommendations

Select License Type

Buy Now

7 Reasons to Choose EHMR Reports

  • Customer’s Satisfaction

    First and foremost client’s satisfaction, which is very important for Erevna Healthcare and we are committed towards it

  • Client Report

    Customised reports

    Expert in healthcare domain and in depth insights on the report. Erevna Healthcare also customise reports as per the client’s requirement

  • Analyst Support

    Experienced team of analysts with strong background in Pharma, Life Sciences and Biotechnology

  • Assured Quality

    Each report passes through three tiers of quality check

  • Stick to the timeline

    Stick to the timeline

    Erevna Healthcare analysts stick to the timeline

  • Quick delivery

    Quick delivery of reports as per client’s request in three different forms i.e. pdf, ppt and word

  • 24x7 Supprt

    24*7 Support

    24*7 Support post delivery/dispatch of all the reports

Trending Reports